MYRELLIA Trademark

Trademark Overview

On Monday, August 26, 2013, a trademark application was filed for MYRELLIA with the United States Patent and Trademark Office. The USPTO has given the MYRELLIA trademark a serial number of 86048234. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, May 28, 2018. This trademark is owned by Actavis, Inc.. The MYRELLIA trademark is filed in the Pharmaceutical Products category with the following description:

Contraceptives; Hormone replacement therapy preparations; Pharmaceutical preparations for the prevention of preterm birth or pregnancy; Pharmaceutical preparations for the treatment and prevention of urinary incontinence and overactive bladder; Pharmaceutical preparations for the treatment and prevention of iron deficiency and anemia; Pharmaceutical preparations for the treatment and prevention of osteoporosis; Pharmaceutical preparations for the treatment and prevention of endometriosis; Pharmaceutical preparations for the treatment and prevention of symptoms associated with uterine fibroids; Iron chelating pharmaceutical preparations; Fertility enhancing preparations
myrellia

General Information

Serial Number86048234
Word MarkMYRELLIA
Filing DateMonday, August 26, 2013
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, May 28, 2018
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 24, 2015

Trademark Statements

Goods and ServicesContraceptives; Hormone replacement therapy preparations; Pharmaceutical preparations for the prevention of preterm birth or pregnancy; Pharmaceutical preparations for the treatment and prevention of urinary incontinence and overactive bladder; Pharmaceutical preparations for the treatment and prevention of iron deficiency and anemia; Pharmaceutical preparations for the treatment and prevention of osteoporosis; Pharmaceutical preparations for the treatment and prevention of endometriosis; Pharmaceutical preparations for the treatment and prevention of symptoms associated with uterine fibroids; Iron chelating pharmaceutical preparations; Fertility enhancing preparations

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, September 5, 2013
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameALLERGAN FINANCE, LLC
Party Type22 - New Owner After Publication
Legal Entity Type16 - Limited Liability Company
AddressPARSIPPANY, NJ 07054
Party NameAllergan Finance, LLC
Party Type21 - New Owner After Publication
Legal Entity Type16 - Limited Liability Company
AddressParsippany 07054
Party NameActavis, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressParsippany, NJ 07054
Party NameActavis, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressParsippany, NJ 07054

Trademark Events

Event DateEvent Description
Tuesday, May 29, 2018ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, May 28, 2018ABANDONMENT - NO USE STATEMENT FILED
Wednesday, January 3, 2018ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Wednesday, October 11, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 10, 2017EXTENSION 5 GRANTED
Thursday, October 5, 2017EXTENSION 5 FILED
Thursday, October 5, 2017TEAS EXTENSION RECEIVED
Thursday, March 30, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 29, 2017AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, March 29, 2017EXTENSION 4 GRANTED
Wednesday, March 22, 2017EXTENSION 4 FILED
Wednesday, March 22, 2017TEAS EXTENSION RECEIVED
Monday, January 30, 2017TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, November 2, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 1, 2016EXTENSION 3 GRANTED
Tuesday, October 18, 2016EXTENSION 3 FILED
Tuesday, October 18, 2016TEAS EXTENSION RECEIVED
Thursday, May 12, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 11, 2016EXTENSION 2 GRANTED
Friday, April 8, 2016EXTENSION 2 FILED
Wednesday, May 11, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, April 8, 2016TEAS EXTENSION RECEIVED
Friday, October 23, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 21, 2015EXTENSION 1 GRANTED
Wednesday, October 21, 2015EXTENSION 1 FILED
Wednesday, October 21, 2015TEAS EXTENSION RECEIVED
Tuesday, April 21, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 24, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 24, 2015PUBLISHED FOR OPPOSITION
Wednesday, February 4, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, January 21, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, January 20, 2015ASSIGNED TO LIE
Tuesday, December 30, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, December 30, 2014EXAMINER'S AMENDMENT ENTERED
Tuesday, December 30, 2014NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, December 30, 2014EXAMINERS AMENDMENT E-MAILED
Tuesday, December 30, 2014EXAMINERS AMENDMENT -WRITTEN
Monday, June 16, 2014REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Tuesday, December 10, 2013NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, December 10, 2013LETTER OF SUSPENSION E-MAILED
Tuesday, December 10, 2013SUSPENSION LETTER WRITTEN
Tuesday, December 10, 2013ASSIGNED TO EXAMINER
Thursday, September 5, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, August 29, 2013NEW APPLICATION ENTERED IN TRAM

Related Keywords

myrellia preparations pharmaceutical prevention treatment iron symptoms endometriosis anemia osteoporosis fibroids